# Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis

> **NCT00111098** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 150 (estimated)

## Conditions studied

- Kidney Disease

## Interventions

- **DRUG:** Darbepoetin Alfa

## Key facts

- **NCT ID:** NCT00111098
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2008-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00111098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00111098, "Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00111098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*